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T cells from Mycobacterium avium-infected C57BL/6 mice reacted to culture filtrate, envelope, and cytosol
proteins and to fractions obtained from these proteins. Multiple targets were recognized, such as 29- to 45-kDa
and <21-kDa antigens of the culture filtrate, antigens of around 30 kDa in the envelope and cytosol, and 45-
to 116-kDa proteins in the envelope.
The identification of the key antigenic targets of the immune
response to mycobacteria is of pivotal importance in the design
and testing of new vaccine candidates against mycobacterial
pathogens, most notably Mycobacterium tuberculosis. Work
from several laboratories has identified secreted/exported pro-
teins from M. tuberculosis as the major targets of a protective
immune response to experimental tuberculosis infections (2, 3,
5, 12, 13, 17, 18, 20). These antigens are also favored targets
during an immune response in human patients infected with
the tubercle bacilli (17). However, other proteins believed not
to be excreted by the mycobacterial cells have also been iden-
tified as important targets, namely in the induction of protec-
tive immune responses in experimental animals (14, 23), sug-
gesting that the complete picture of the immune response to
mycobacterial infections may be more complex with regard to
the antigenic repertoire recognized in vivo. Mycobacterium
avium is an opportunistic pathogen that is thought to interfere,
in certain areas of the world, with the efficacy of the only
tuberculosis vaccine in use today, the attenuated Mycobacte-
rium bovis strain bacille Calmette-Gue´rin (BCG) (9). The rea-
son for the failure of vaccination trials is not known, but it has
been speculated that sensitization of human beings to antigens
from environmental mycobacteria might affect BCG efficacy,
most likely because all mycobacteria would share common
antigens. Sharing of antigens between nontuberculous myco-
bacteria and BCG was already shown to occur at the immu-
nological level in mice (15). However, except for two defined
antigens, the latter study used crude extracts that combined
many different antigens. The sharing of common antigens
between M. avium, BCG, and M. tuberculosis will be under-
stood in the near future thanks to efforts in the area of
genomics. However, we still need studies in the fields of
proteomics and immunology to generate functional data and
therefore to be able to critically analyze the genomic informa-
tion, namely studying native proteins rather than recombinant
ones, as the latter may lack the immunogenicity of the former
(1, 21). Thus, we initiated the characterization of the T-cell
response to M. avium protein antigens using a mouse model of
infection.
We isolated antigens from M. avium 2447, an AIDS patient
isolate obtained from F. Portaels (Institute of Tropical Medi-
cine, Antwerp, Belgium) that forms smooth transparent colo-
nies when cultured on solid media. Mycobacteria from log-
phase cultures were inoculated into Sauton medium enriched
with 0.5% sodium pyruvate and 0.5% glucose (Sauton P1G)
(8) and with no detergent, at a final concentration of approx-
imately 5 3 106 CFU/ml (according to the absorbance mea-
sured at 600 nm), and grown at 37°C without shaking. The
number of viable bacteria and the smooth transparent mor-
photype were confirmed by plating serial dilutions of the cul-
tures on solid Middlebrook 7H10 medium (Difco, Sparks,
Md.). At the end of log phase (i.e., at day 15 as evaluated from
the previous growth curves), cultures were centrifuged for pro-
cessing of bacterial antigens. Culture filtrate proteins were
obtained from the filter-sterilized supernatant of the culture by
ultrafiltration in a stirred cell (Millipore, Bedford, Mass.) with
an Amicon YM membrane (molecular weight cut-off [MWCO]
of 3,000) (Millipore). The concentrate was precipitated with
80% ammonium sulfate, and the precipitate was washed in a
Centriprep (MWCO of 3,000) (Millipore). Cytosolic and en-
velope proteins were obtained after the pellet was washed
twice with phosphate-buffered saline (PBS), resuspended in
PBS containing 0.1% Tween 80 (Sigma), 1 mM MgCl2 (Merck,
Darmstadt, Germany) and 1 mM benzamidine (Sigma) (10),
and disrupted through sonication with pulses of 1 min at
maximum power, with the sample kept in ice during the
whole procedure. The sonicate was centrifuged to discard
intact mycobacteria (30 min at 2,700 3 g), and the super-
natant was dialyzed against PBS (MWCO of 12,000). The
suspension was then ultracentrifuged for 2 h at 150,000 3 g.
The pellet containing the envelope proteins was resus-
pended in PBS, and the supernatant enriched in cytosolic
proteins was precipitated with 80% ammonium sulfate and
dialyzed against PBS.
Following the preparative procedures described above, we
obtained crude extracts which were analyzed to assess if they
were distinct sources of antigens. Cytosolic, envelope, and
culture filtrate proteins (20 mg) were separated in a 10 to
20% gradient sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) gel and analyzed either by silver
staining or by Western blotting after transfer to a PROTON
nitrocellulose (Schleicher and Schuell, Dassel, Germany)
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membrane in a semidry electrophoretic transfer cell (Bio-Rad,
Richmond, Calif.). During the latter procedure, the membrane
was blocked in PBS containing 0.5% Tween 20 (Sigma), incu-
bated for 2 h at room temperature with the antibodies diluted
(1:50) in PBS–0.05% Tween–0.37 M NaCl, and washed in the
dilution buffer. The primary antibodies used were specific for
DnaK (clone HÅT 3), GroEL (clone HÅT 5), GroES (clone
HYB 76-1), and Ag85 (clone HYT 27), and they were kindly
provided by Peter Andersen (Statens Seruminstitut, Copen-
hagen, Denmark). The secondary antibody, a horseradish
peroxidase-coupled sheep anti-mouse antibody (Amersham-
Pharmacia Biotech, Little Chalfont, United Kingdom) was
incubated at a 1:500 dilution for 2 h at room temperature. The
specific protein complexes were detected using the ECL re-
agents (Amersham-Pharmacia Biotech).
The protein profiles observed in the silver-stained gels for
the three fractions were different, with distinct, different major
bands obtained with the three preparations (Fig. 1A). The
immunochemical analysis by the Western blotting with the
panel of monoclonal antibodies against well-defined myco-
bacterial proteins (DnaK, GroEL, Ag85 complex, and GroES)
showed that the three protein preparations corresponded to dis-
tinct cellular compartments. Thus, the DnaK and GroES pro-
teins were mostly found in the cytosolic preparations, whereas
the GroEL protein was found exclusively in the envelope frac-
tion. Although we could find Ag85 in all three compartments,
the molecular weight (MW) pattern varied, with higher-MW
forms being found in the cytosol and envelope and a low-
er-MW form being found in the culture filtrate. We thus con-
clude that the culture filtrate and envelope preparations have
negligible contamination with cytosol proteins. These prepara-
tions were then studied in terms of their ability to stimulate T
cells isolated from infected mice. Six-week-old C57BL/6J fe-
male mice (Harlan Iberia, Madrid, Spain) were infected intra-
venously with 106 CFU of M. avium 2447 (smooth transparent
morphotype) through a lateral tail vein at different time points
and sacrificed on the same day at different times of infection to
perform the in vitro stimulation of splenic cells. At days 15, 30,
60, and 90 after infection, spleens were removed and single-cell
suspensions were prepared. Cells were washed with RPMI–2%
fetal calf serum (FCS), and the erythrocytes were lysed with a
hemolytic solution (155 mM NH4Cl–10 mM KHCO3, pH 7.2).
The cells were cultured in Dulbecco’s modified Eagle medium
(Life Technologies, Paisley, United Kingdom) supplemented
with HEPES buffer, pyruvate, and 10% FCS. The cells were
cultured in 96-well, round-bottom, microtiter tissue culture plates
FIG. 1. Analysis of crude extracts of M. avium 2447 proteins. Cytosol (Cyt.), envelope (Env.), and culture filtrate (CF) preparations were analyzed by gradient (10
to 20%) SDS-PAGE followed by silver staining (A) or transferred to nitrocellulose and incubated with antibodies against DnaK, GroEL, Ag85 complex, or GroES
followed by ECL-dependent detection of antigen-positive bands (B).
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(Nunc, Roskilde, Denmark), each well containing 2 3 105 cells
in a volume of 200 ml with no stimulus or incubation in the
presence of antigen at a final concentration of 4 mg of crude
extract/ml. Culture supernatants from triplicate wells were har-
vested 72 h later for the detection of gamma interferon
(IFN-g) as a readout of the response of those T cells to the
different antigens using an enzyme-linked immunosorbent as-
say (ELISA) as previously described (22). As shown in Fig. 2,
the envelope proteins were strong stimulators of IFN-g pro-
duction from day 15 of infection. The three preparations had
antigens that stimulated T cells from mice infected for 30, 60,
or 90 days, with the highest amount of IFN-g being produced
at day 30 of infection.
To obtain panels of MW fractions from the culture filtrate,
envelope, and cytosol preparations, the multielution technique
(4) was used. Briefly, 7 mg of culture filtrate or cytosolic pro-
teins or 9 mg of envelope proteins was separated by SDS-
PAGE (with a gradient gel of 10 to 20% acrylamide), and the
gel was prepared for electroelution as described before (4).
The proteins were electroeluted (40 V) for 20 min into a 2-mM
phosphate buffer in a whole-gel eluter (Bio-Rad) in a cold
room. The fractions were collected and analyzed (40 ml of each
fraction) in a gradient SDS-PAGE (10 to 20% acrylamide)
after fixation and silver staining (16). Protein concentration
was quantified by the Micro BCA method (Pierce, Rockford,
Ill.). The fractions were stabilized with 0.5% FCS in PBS. The
SDS-PAGE analysis of the fractions obtained showed that
most of them contained proteins in a very narrow range of
MWs (Fig. 3), thereby greatly reducing the complexity of the
crude extracts. The fractions obtained were then used to study
the antigenic specificity of the T cells from infected mice, as
detailed above (Fig. 4). The in vitro stimulation of spleen cells
with the MW fractions obtained from the three different com-
partments at a final concentration of 2 mg/ml showed that the
response to the culture filtrate fractions emerged at day 15,
earlier than the response to the cytosol or envelope fractions.
At day 30 of infection, the peak of the response, the strongest
stimulators of T cells were found among fractions of culture
filtrate in the 29,000-to-45,000 MW range. Fraction 13 from
the culture filtrate, which was enriched in proteins in the 30-
kDa region (where proteins such as Ag85 complex, a group of
proteins that are highly immunogenic among mycobacteria
(11, 24), are expected to locate), induced the strongest IFN-g
production. Fractions 12 of the cytosol and envelope, which
contain proteins in the same region of MW, were also very
immunogenic. Fractions from the envelope between 45 and
116 kDa contained highly stimulatory proteins that were ab-
sent from the corresponding MW fractions of the culture fil-
trate. On the other hand, there was a group of fractions in the
culture filtrate below 21 kDa (fractions 17 to 21), which did not
include the lowest-MW fractions, that were also inducers of
IFN-g production.
The antigen repertoire recognized by IFN-g-secreting T
cells during an M. avium infection in mice revealed a highly
diverse set of protein antigens. The antigen targets were not
confined to the secreted/exported proteins but rather were
promiscuous among all compartments of the mycobacterial
cell when grossly dissected into secreted/exported (culture fil-
trate), envelope, and cytoplasmic proteins. Several groups have
FIG. 2. Antigenicity of the crude extracts of M. avium 2447 proteins. Single-
cell suspensions were prepared from spleens of mice infected for 15 (T15), 30
(T30), 60 (T60), or 90 (T90) days with M. avium 2447 or noninfected (naive)
animals and stimulated in vitro with 4 mg of cytosol, envelope, or culture filtrate
proteins per ml. IFN-g release was quantified by ELISA in the 72-h culture
supernatants. Results are expressed as means of values of triplicate samples 61
standard deviation performed on cells pooled from four mice. Statistically sig-
nificant differences compared to values for nonstimulated cells are labeled: p,
P , 0.05; pp, P , 0.01; ppp, P 5 0.00.
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favored secreted/exported proteins as the major targets of the
protective immune response to M. tuberculosis (2, 3, 5, 12, 13,
17, 18, 20). In addition, cell wall-associated proteins have also
been shown to evoke an immune response during infection
(17), suggesting their shedding from the cell wall during growth
of mycobacteria inside the vacuoles of the infected macro-
phage. Finally, the response to cytoplasmic antigens would,
according to some, appear later in infection as a result of the
killing of the mycobacteria, and this response would be asso-
ciated not with a protective IFN-g-mediated immune response
but most likely with a type 2 immune response, which is puta-
tively associated with removal of the dead mycobacteria
(19). Our data confirm the above paradigm by showing im-
portant reactivity towards secreted/exported as well as en-
velope proteins. However, IFN-g-secreting T cells were also
found to respond to the cytosolic proteins, namely to fractions
of around 30 to 32 kDa, characteristic of the Ag85 complex.
Although it is believed that this is a typical secretion antigen
(24, 25), we detected its presence in both the somatic (cytosol
and envelope) and secreted fractions. Curiously, the former
forms had a higher MW than the secreted form. The fact that
Ag85 is found in the envelope is not surprising due to its
function in the synthesis of the cell wall (7). Its presence in the
cytosol may be due to contamination during preparation of the
antigens, e.g., by its release from the cell wall during sonication
of the bacilli, and it could justify reactivity to the cytosol.
Otherwise, we are rather confident that cross-contamination
represents negligible components of each fraction, since we
found no traces of DnaK, GroEL, or GroES in the culture
filtrates, whereas their presence in the cytoplasm or envelope
was clearly detectable by Western blotting. This finding con-
trasts with the data reported for M. tuberculosis, where the heat
shock proteins DnaK, GroEL, and GroES were found in the
short-term culture filtrate (3). Although GroES has been de-
scribed as a major T-cell antigen recognized by cells from
tuberculosis patients and infected animals (6, 18), we failed to
observe any reactivity to the fractions of the cytosol expected to
contain this antigen. This might be explained by the fact that
only the molecule isolated from culture filtrates is able to
stimulate T cells, as elegantly shown by Rosenkrands and col-
leagues (21).
The fractionation techniques utilized in this work are not
precise enough to identify single antigens but are suitable for
an initial screening of the responses against the whole pro-
teome. They are adequate for the kind of kinetic study pre-
sented here, which would be extremely laborious with other
methods, such as those relying on two-dimensional separation
procedures. They also have the advantage of using native an-
tigens, which may differ from the recombinant products. The
data generated here may, on the other hand, guide us to select
groups of antigens separated through more potent techniques.
Our data also raise interesting speculations regarding the field
of vaccine development by suggesting that antigens from dif-
ferent compartments may be adequate candidates for the gen-
eration of protection. Also, it will be important to understand
whether an improvement on the protective efficacy of subunit
vaccines based on culture filtrate protein can be obtained by
adding proteins from other sources of the mycobacterial cell.
The fact that the responses to the antigens showed distinct
kinetics raises the possibility that antigens from different com-
partments may be involved in protection at distinct stages of
the disease. In this context it should be mentioned that vacci-
nation with HSP60-expressing DNA vaccines had a major im-
pact on experimental tuberculosis when performed during in-
fection as a therapeutical vaccine, whereas a similar construct
expressing a secreted antigen had no effect (14); on the other
hand, both antigens prevented infection when given prior to
bacillary challenge (3, 23). It would be interesting to follow up
the present observations and reanalyze the antigenic repertoire
in experimental tuberculosis. Finally, it should be stressed that
the reactivities against M. avium proteins observed here were
determined by the proteins expressed during culture in a par-
ticular medium. Other proteins may be expressed in other
media and, more importantly, other proteins may be ex-
pressed in vivo and not in vitro. It is therefore still necessary
to broaden this type of analysis to fully understand the
nature of the immunogenic proteome of M. avium in the
context of infection.
We are indebted to P. Andersen for his support in the setting up of
the analytical methods used, for the gift of reagents, and for fruitful
discussions.
The work was supported by contracts ERBIC18CT970254 from the
INCO/DC Programme (European Commission) and BIA247/94 from
the PRAXIS Programme (Lisbon). T.F.P. and J.F.C. received fellow-
ships from PRAXIS.
FIG. 3. Fractionation of cytosol, envelope, and culture filtrate (CF) proteins.
Proteins were separated by SDS-PAGE and electroeluted as described in the
text. The different MW fractions were analyzed on a silver-stained SDS-PAGE
gel.
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FIG. 4. Antigenicity of the fractions obtained from cytosol, envelope, and culture filtrate proteins (the fraction numbers on this figure correspond to the numbers
in Fig. 3). Spleen cells of noninfected mice or mice infected with M. avium 2447 were stimulated in vitro with 2 mg of each fraction per ml. IFN-g release was quantified
by ELISA with culture supernatants.
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